Stryker Corporation (SYK) To Go Ex-Dividend on September 30th

Stryker Corporation (NYSE:SYK) announced a quarterly dividend on Tuesday, August 4th. Stockholders of record on Wednesday, September 30th will be given a dividend of 0.88 per share by the medical technology company on Friday, October 30th. This represents a c) dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Wednesday, September 30th.

Stryker has raised its dividend by an average of 0.1%per year over the last three years and has increased its dividend every year for the last 32 years. Stryker has a dividend payout ratio of 23.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect Stryker to earn $16.75 per share next year, which means the company should continue to be able to cover its $3.52 annual dividend with an expected future payout ratio of 21.0%.

Stryker Trading Down 0.2%

Shares of NYSE:SYK traded down $0.66 on Thursday, reaching $336.37. 195,541 shares of the company traded hands, compared to its average volume of 2,368,833. The company has a current ratio of 2.16, a quick ratio of 1.33 and a debt-to-equity ratio of 0.59. Stryker has a 52 week low of $281.00 and a 52 week high of $396.86. The stock has a market capitalization of $129.02 billion, a P/E ratio of 34.87, a price-to-earnings-growth ratio of 2.14 and a beta of 0.76. The business’s 50-day simple moving average is $318.85 and its 200 day simple moving average is $334.29.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The company had revenue of $6.59 billion for the quarter, compared to the consensus estimate of $6.58 billion. During the same quarter in the previous year, the business earned $3.13 EPS. Stryker’s revenue was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, equities analysts anticipate that Stryker will post 15.02 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on SYK. Wells Fargo & Company dropped their price target on shares of Stryker from $456.00 to $418.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. The Goldman Sachs Group reissued a “neutral” rating and issued a $361.00 target price on shares of Stryker in a report on Friday, May 1st. Citigroup reaffirmed an “outperform” rating on shares of Stryker in a report on Monday. Citizens Jmp cut their target price on Stryker from $440.00 to $400.00 and set a “market outperform” rating for the company in a research report on Monday. Finally, BTIG Research lowered their price target on Stryker from $371.00 to $358.00 and set a “buy” rating on the stock in a report on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, Stryker presently has a consensus rating of “Moderate Buy” and an average target price of $386.28.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.